Disclosure of interest: Yong-Jin Cho : nothing to disclosure Jong-Moo Park : nothing to disclosure Kyung Bok Lee : nothing to disclosure Ji Sung Lee : nothing to disclosure Tai Hwan Park : nothing to disclosure Keun-Sik Hong : nothing to disclosure Hong-Kyun Park : nothing to disclosure Kyusik Kang : nothing to disclosure Jae Kwan Cha : nothing to disclosure Soo Joo Lee : nothing to disclosure Jun Lee : nothing to disclosure Mi Sun Oh : nothing to disclosure Juneyoung Lee : nothing to disclosure Beom Joon Kim : nothing to disclosure Hee-Joon Bae : nothing to disclosure Poster Session I - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P055 - ESOC25-914 QUALITY OF ACUTE STROKE CARE IN REPUBLIC OF MOLDOVA: ACHIEVEMENTS IN 2024 Stanislav Groppa 1,2,3 , Diana Manea *1 , Mihai Ciocanu 1 , Zota Eremei 1,2 , Natalia Ciobanu 1,2 , Ecaterina Turcan 1,2 , Felicia Glavan 1,2 1 Institute of Emergency Medicine, Department of Neurology, Chisinau, Moldova, 2 Nicolae Testemitanu State University of Medicine and Pharmacy, Department of Neurology nr
Safety Warnings: The drug should not be used if you are hypersensitive to any of its ingredients
The formula is safe for weekly use without adverse effects, and over 100,000 cases treated across the Aura network confirm its tolerability and efficacy
Cell Migration and Tissue Remodeling
Huttlin EL, et al
(PubMed) Varkal MA, Karabocuoglu M
